# Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

> **NCT01753310** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 134 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01753310
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-01
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753310, "Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01753310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
